Savvy Updates, 10/17/22: Dexcom G7 Global Rollout, T2D Drugs Help T1Ds, BefA Gut Bacteria & Beta Cell Production, FDA TAP Pilot Program for New D Devices
Dexcom Announces Global Rollout of G7, as reported by Andrew Briskin for diaTribe.org, 10 October 2022. Dexcom, one of the leading manufacturers of CGM, announced on Oct. 4 that its latest product, the Dexcom G7, is now available for people with diabetes, ages 2...
Savvy Updates, 10/10/22: Indigo Continuous Multi-Metabolite (CMM) Sensor, T1D More Difficult/Dangerous for Girls
Indigo Diabetes enrolls first subject in multi-metabolite sensor trial was published by MedicalDevice-Network.com, 30 September 2022. Belgian diabetes device company Indigo Diabetes has enrolled the first participant in the Shine (multi-center, open-label,...
Savvy Apps 10/6/22: Gluroo with Greg Badros, CEO/Developer
Join Loop and Learn for a FREE Zoom Event about a cool app for T1Ds. GLUROO with Greg Badros The Diabetes Logging app that makes managing diabetes as easy as messaging Sunday, 9 October 2022, 5pm PT/8pm ET Zoom: https://us02web.zoom.us/j/84171589505 YouTube...
Savvy Updates, 10/3/22: EASD 2022 Highlights, Diabetes Product Waste, All About Fat, Bolusing for Fats & Proteins
Highlights From EASD 2022 was written by Andrew Briskin, Arvind Sommi and Natalie Sainz for diaTribe.org, 21 September 2022. Here’s a great overview of presentations at this year’s EASD (European Association for the Study of Diabetes) Annual Meeting, held...
Interview by Kamil Armacki (aka, Nerdabetic) with Dexcom’s Jake Leach, 23 September 2022
Kamil Armacki shared on his YouTube channel: As many of you know Dexcom G7 was CE marked earlier this year. During this year’s annual EASD conference in Stockholm, Sweden (September 2022), I sat down with Dexcom’s Jake Leach – Chief Operating...
Savvy Updates, 9/26/22: Medtronic Pumps & Cybersecurity Risk, Diabeloop Algorithm Increases TIR, T1D & UTIs, Moderate Diabetes Distress Even with CGM
FDA Warns of Cybersecurity Risk With Medtronic MiniMed 600 Series Insulin Pumps was reported by David Kerr, MD, for Healio.com/endocrinology, 20 September 2022. The FDA has issued an alert warning people with diabetes using a Medtronic MiniMed 630G or MiniMed 670G...
Savvy Updates, 9/19/22: Investor Lawsuit against Medtronic, Synthetic Human Gut Microbiome, Sex of Researcher Affects Study Outcomes, Loss of “Caring” in Healthcare
Investor lawsuit accuses Medtronic of failing to disclose insulin pump problems was posted by Mick Paul Taylor for MedTechDive.com, 13 September 2022. Investors have accused Medtronic of failing to disclose problems with its insulin pump business that...
Savvy Updates 9/12/22: Novo saves Zegalogue, Sugar Disrupts Microbiome, Cravings for Fatty Foods, DPAC Sues HHS for Copay Accumulators, Best Places for Dexcom G6 Sensor
Zealand summons Novo Nordisk to resuscitate floundering diabetes newcomer Zegalogue was reported by Fraiser Kansteiner for FiercePharma.com, 7 September 2022. Zealand said it has forged a global license and development pact with Novo Nordisk to take the marketing...
Savvy Updates, 9/6/22: Senseonics CFO Leaves, Beta Bionics Trial Data & RIF, Chip-free, Wireless Electronic Skin, Insulin Pill, Cognitive Benefits from Hybrid Closed Loop Systems, Sugar & Microbiome, T1D & Hypothyroidism
Senseonics Announces CFO Transition was published by Senseonics Holdings, Inc., 1 September 2022. Senseonics, a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems...
More Diabetes Blogs